No definitive treatment exists for chronic traumatic encephalopathy. However novel drugs such as salsalate that precisely inhibit the essential steps of acetylation before phosphorylation of the paired helical filament-6 (PHF-6) motif, thereby inhibiting microglial activation are under research.